找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Combination Therapy in Hypertension; Joel M. Neutel Book 2011 Springer Healthcare 2011 Combination Therapy.Hypertension.Polypharmacy.blood

[復制鏈接]
查看: 6957|回復: 43
樓主
發(fā)表于 2025-3-21 18:36:48 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Combination Therapy in Hypertension
編輯Joel M. Neutel
視頻videohttp://file.papertrans.cn/230/229860/229860.mp4
概述Dr Neutel is an innovative and leading specialist in clinical hypertension and a prominent advocate of the need for combination therapy in its treatment.This concise pocket book provides concise pract
圖書封面Titlebook: Combination Therapy in Hypertension;  Joel M. Neutel Book 2011 Springer Healthcare 2011 Combination Therapy.Hypertension.Polypharmacy.blood
描述For over 30 years, the stepped care approach has been used in the management and treatment of hypertension. This approach advocates the use of initial monotherapy to reach the desired blood pressure, and the subsequent use of additional drugs with complementary modes of action, until the target BP is achieved. However, current control rates for hypertension suggest that such an approach may be outdated and no longer effective in the management of hypertension. Clinical trials have shown that more than 50% of patients require a combination of drug therapies to achieve their target BP. Some proponents of combination therapy have argued that the risk of adverse side effects and non-compliance will be lower than that compared to monotherapy, which initially requires higher doses to be administered to be effective. Consequently, there have been increasing calls of the necessity for a much more combined approach in the treatment of hypertension. Adding to this, Combination Therapy in Hypertension will cover current control rates of blood pressure worldwide, the benefits of monotherapy and combination therapy, examine the effectiveness, risk of adverse effects, compliance, and cost of the
出版日期Book 2011
關(guān)鍵詞Combination Therapy; Hypertension; Polypharmacy; blood pressure; cardiovascular; patients; pharmacotherapy
版次1
doihttps://doi.org/10.1007/978-1-908517-28-9
isbn_softcover978-1-908517-25-8
isbn_ebook978-1-908517-28-9
copyrightSpringer Healthcare 2011
The information of publication is updating

書目名稱Combination Therapy in Hypertension影響因子(影響力)




書目名稱Combination Therapy in Hypertension影響因子(影響力)學科排名




書目名稱Combination Therapy in Hypertension網(wǎng)絡(luò)公開度




書目名稱Combination Therapy in Hypertension網(wǎng)絡(luò)公開度學科排名




書目名稱Combination Therapy in Hypertension被引頻次




書目名稱Combination Therapy in Hypertension被引頻次學科排名




書目名稱Combination Therapy in Hypertension年度引用




書目名稱Combination Therapy in Hypertension年度引用學科排名




書目名稱Combination Therapy in Hypertension讀者反饋




書目名稱Combination Therapy in Hypertension讀者反饋學科排名




單選投票, 共有 1 人參與投票
 

1票 100.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 21:29:41 | 只看該作者
板凳
發(fā)表于 2025-3-22 02:22:41 | 只看該作者
地板
發(fā)表于 2025-3-22 05:16:00 | 只看該作者
Sir Philip Sidney, Cultural Icon studies indicate that administration of low-dose combination therapy enables adequate blood pressure control to be achieved in all subgroups of hypertensive patients, including the elderly, African–Americans, Caucasians, and patients with diabetes or metabolic syndrome.
5#
發(fā)表于 2025-3-22 08:52:59 | 只看該作者
Sir Philip Sidney, Cultural Iconbination therapy may result in greater decreases in systolic blood pressure, a higher rate of control of blood pressure, and a better adverse event profile than do component monotherapies at the same or higher doses.
6#
發(fā)表于 2025-3-22 15:41:58 | 只看該作者
The Crisis in Church and State,percentage of controlled patients has decreased. Also, significantly, the lower target for blood pressure has created a greater challenge for physicians, who were already having difficulty achieving the 140/90?mmHg goal in their patients.
7#
發(fā)表于 2025-3-22 17:33:41 | 只看該作者
Advantages of Combination Therapy Compared with Monotherapy,plementary antihypertensive drugs in combination is always associated with greater efficacy than uptitration of an individual antihypertensive agent and provides an improved adverse event profile compared with monotherapy.
8#
發(fā)表于 2025-3-22 22:49:09 | 只看該作者
Use of Combination Therapy in Special Populations, studies indicate that administration of low-dose combination therapy enables adequate blood pressure control to be achieved in all subgroups of hypertensive patients, including the elderly, African–Americans, Caucasians, and patients with diabetes or metabolic syndrome.
9#
發(fā)表于 2025-3-23 04:33:04 | 只看該作者
10#
發(fā)表于 2025-3-23 09:04:25 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-17 15:47
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復 返回頂部 返回列表
于都县| 北川| 丹寨县| 鸡西市| 永平县| 江川县| 新建县| 江油市| 读书| 临沧市| 安平县| 阳信县| 府谷县| 塔城市| 诏安县| 蓬安县| 永川市| 赣州市| 阳西县| 龙山县| 桂平市| 江津市| 富锦市| 阿合奇县| 三江| 麦盖提县| 石泉县| 潮州市| 建瓯市| 天镇县| 伽师县| 丹巴县| 黔江区| 石阡县| 孟村| 青川县| 连平县| 曲松县| 钦州市| 梨树县| 濉溪县|